Latest Intrinsa Stories
Currently, there are no FDA-approved drugs for female sexual dysfunction, even though it is a major concern among women, especially women in menopause.
The drug industryâ€™s latest attempt to find a female equivalent to Viagra fell short in two separate studies, according to federal regulators on Wednesday.
U.S. researchers are testing the drug LibiGel to see if it will safely boost the libido of post-menopausal women. The drug is a gel formulation of testosterone that delivers the hormone to the bloodstream through a once-daily application on the upper arm.
A top medical journal review claims that Procter & Gamble's Intrinsa testosterone patches appear to do little to boost a woman's sex drive after menopause, Reuters reported.
A U.S. sex therapist suggests testosterone therapy for women may leave much to be desired. Dr. Domeena Renshaw of Loyola University Health System in Chicago says testosterone therapy may not be the magic bullet women with low libidos have been hoping for.
BioSante Pharmaceuticals, Inc.
Australian researchers suggest a testosterone patch may significantly improve flagging libidos in older women, though there are side effects. The side effects in the study of more than 800 postmenopausal women who weren't on estrogen therapy who reported low sexual desire included unwanted hair.
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that it successfully has completed and reached an additional agreement with the U.S.
NEW YORK - A hysterectomy 11 years ago zapped Colleen Christensen's sexual desire. Now 55 years old and married for 33 years, Christensen said she used to worry that a lack of intimacy was draining the fun and closeness from her relationship.
CHEVY CHASE, Md., Nov.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.